25 XP   0   0   10

Ironwood Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Ironwood Pharmaceuticals Inc together

PenkeI guess you are interested in Ironwood Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ironwood Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ironwood Pharmaceuticals Inc

I send you an email if I find something interesting about Ironwood Pharmaceuticals Inc.

Quick analysis of Ironwood Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Ironwood Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-2.07
Expected worth in 1 year
€-8.03
How sure are you?
62.1%

+ What do you gain per year?

Total Gains per Share
€-5.96
Return On Investment
-80.0%

For what price can you sell your share?

Current Price per Share
€7.45
Expected price per share
€0 - €13.40
How sure are you?
50%

1. Valuation of Ironwood Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

€7.45

Intrinsic Value Per Share

€6.56 - €7.29

Total Value Per Share

€4.50 - €5.22

2. Growth of Ironwood Pharmaceuticals Inc (5 min.)




Is Ironwood Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$346.2m$573.5m-$651.4m-835.5%

How much money is Ironwood Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$250.5m$43.7m-$294.3m-117.5%
Net Profit Margin-233.2%42.5%--

How much money comes from the company's main activities?

3. Financial Health of Ironwood Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Ironwood Pharmaceuticals Inc? (5 min.)

Welcome investor! Ironwood Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Ironwood Pharmaceuticals Inc.

What can you expect buying and holding a share of Ironwood Pharmaceuticals Inc?

First you should know what it really means to hold a share of Ironwood Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Ironwood Pharmaceuticals Inc is €7.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ironwood Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ironwood Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-2.07. Based on the TTM, the Book Value Change Per Share is €-1.49 per quarter. Based on the YOY, the Book Value Change Per Share is €0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ironwood Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.01-0.1%-3.37-45.2%0.283.8%-0.41-5.6%-0.37-4.9%
Usd Book Value Change Per Share-0.13-1.8%-1.60-21.4%0.111.4%-0.05-0.7%-0.08-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.13-1.8%-1.60-21.4%0.111.4%-0.05-0.7%-0.08-1.0%
Usd Price Per Share10.81-10.30-12.00-10.79-12.01-
Price to Earnings Ratio-389.13--91.32-10.94--4.06--6.32-
Price-to-Total Gains Ratio-82.07-4.39-39.26-29.89--24.66-
Price to Book Ratio-4.89--2.98-3.30-8.54-25.39-
Price-to-Total Gains Ratio-82.07-4.39-39.26-29.89--24.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.97299
Number of shares125
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.60-0.05
Usd Total Gains Per Share-1.60-0.05
Gains per Quarter (125 shares)-199.38-6.85
Gains per Year (125 shares)-797.51-27.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-798-8080-27-37
20-1595-16060-55-64
30-2393-24040-82-91
40-3190-32020-110-118
50-3988-40000-137-145
60-4785-47980-164-172
70-5583-55960-192-199
80-6380-63940-219-226
90-7178-71920-247-253
100-7975-79900-274-280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%9.03.00.075.0%16.04.00.080.0%17.012.00.058.6%17.012.00.058.6%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%18.011.00.062.1%18.011.00.062.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%18.011.00.062.1%18.011.00.062.1%

Fundamentals of Ironwood Pharmaceuticals Inc

About Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-18 08:03:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ironwood Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ironwood Pharmaceuticals Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -0.9% means that €-0.01 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is -0.9%. The company is not making a profit/loss.
  • The TTM is -233.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-233.2%+232.2%
TTM-233.2%YOY42.5%-275.6%
TTM-233.2%5Y-8.5%-224.6%
5Y-8.5%10Y-26.9%+18.4%
1.1.2. Return on Assets

Shows how efficient Ironwood Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.2% Return on Assets means that Ironwood Pharmaceuticals Inc generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is -0.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-42.4%+42.1%
TTM-42.4%YOY4.2%-46.5%
TTM-42.4%5Y-3.6%-38.8%
5Y-3.6%10Y-5.3%+1.7%
1.1.3. Return on Equity

Shows how efficient Ironwood Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Ironwood Pharmaceuticals Inc generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.6%-1.6%
TTM1.6%YOY7.6%-6.0%
TTM1.6%5Y40.9%-39.3%
5Y40.9%10Y-5.7%+46.6%

1.2. Operating Efficiency of Ironwood Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ironwood Pharmaceuticals Inc is operating .

  • Measures how much profit Ironwood Pharmaceuticals Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM13.0%-13.0%
TTM13.0%YOY60.8%-47.8%
TTM13.0%5Y34.7%-21.7%
5Y34.7%10Y12.6%+22.1%
1.2.2. Operating Ratio

Measures how efficient Ironwood Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.63 means that the operating costs are €0.63 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.632. The company is efficient in keeping operating costs low. +1
  • The TTM is 3.157. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.632TTM3.157-2.524
TTM3.157YOY0.392+2.765
TTM3.1575Y1.116+2.041
5Y1.11610Y1.270-0.154

1.3. Liquidity of Ironwood Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.84 means the company has €0.84 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.845. The company is just not able to pay all its short-term debts. -1
  • The TTM is 9.781. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ0.845TTM9.781-8.936
TTM9.781YOY21.924-12.143
TTM9.7815Y11.720-1.939
5Y11.72010Y9.268+2.452
1.3.2. Quick Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.47 means the company can pay off €0.47 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.468. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.539. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.468TTM1.539-1.071
TTM1.539YOY3.483-1.944
TTM1.5395Y2.334-0.795
5Y2.33410Y2.215+0.119

1.4. Solvency of Ironwood Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ironwood Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ironwood Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.74 means that Ironwood Pharmaceuticals Inc assets are financed with 173.5% credit (debt) and the remaining percentage (100% - 173.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 1.735. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.330. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.735TTM1.330+0.405
TTM1.330YOY0.454+0.876
TTM1.3305Y0.977+0.353
5Y0.97710Y1.020-0.043
1.4.2. Debt to Equity Ratio

Measures if Ironwood Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ironwood Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.159-0.159
TTM0.159YOY0.843-0.684
TTM0.1595Y5.072-4.914
5Y5.07210Y11.656-6.584

2. Market Valuation of Ironwood Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Ironwood Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Ironwood Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -389.13 means the investor is paying €-389.13 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is -287.031. Based on the earnings, the company is expensive. -2
  • The MRQ is -389.129. Based on the earnings, the company is expensive. -2
  • The TTM is -91.323. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-287.031MRQ-389.129+102.098
MRQ-389.129TTM-91.323-297.806
TTM-91.323YOY10.941-102.264
TTM-91.3235Y-4.057-87.266
5Y-4.05710Y-6.322+2.265
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is 8.758. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.874. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.058. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.758MRQ11.874-3.115
MRQ11.874TTM10.058+1.816
TTM10.058YOY6.926+3.132
TTM10.0585Y6.990+3.068
5Y6.99010Y4.821+2.169
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ironwood Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -4.89 means the investor is paying €-4.89 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Ironwood Pharmaceuticals Inc:

  • The EOD is -3.604. Based on the equity, the company is expensive. -2
  • The MRQ is -4.886. Based on the equity, the company is expensive. -2
  • The TTM is -2.984. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.604MRQ-4.886+1.282
MRQ-4.886TTM-2.984-1.902
TTM-2.984YOY3.303-6.287
TTM-2.9845Y8.538-11.522
5Y8.53810Y25.392-16.854
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ironwood Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.123-1.490+1111%0.100-223%-0.051-58%-0.071-42%
Book Value Per Share---2.067-0.465-77%3.424-160%0.909-327%0.563-467%
Current Ratio--0.8459.781-91%21.924-96%11.720-93%9.268-91%
Debt To Asset Ratio--1.7351.330+30%0.454+282%0.977+78%1.020+70%
Debt To Equity Ratio---0.159-100%0.843-100%5.072-100%11.656-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.006-3.149+48431%0.261-102%-0.388+5874%-0.344+5200%
Free Cash Flow Per Share--0.2130.273-22%0.408-48%0.325-35%0.325-35%
Free Cash Flow To Equity Per Share---0.0911.277-107%0.054-269%0.493-119%0.493-119%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.290--------
Intrinsic Value_10Y_min--6.565--------
Intrinsic Value_1Y_max--1.314--------
Intrinsic Value_1Y_min--1.291--------
Intrinsic Value_3Y_max--3.503--------
Intrinsic Value_3Y_min--3.353--------
Intrinsic Value_5Y_max--5.156--------
Intrinsic Value_5Y_min--4.824--------
Market Cap1166140990.400-36%1580942819.2001507178531.720+5%1755472645.280-10%1623717815.120-3%1853924816.500-15%
Net Profit Margin---0.009-2.332+25116%0.425-102%-0.085+822%-0.269+2807%
Operating Margin---0.130-100%0.608-100%0.347-100%0.126-100%
Operating Ratio--0.6323.157-80%0.392+61%1.116-43%1.270-50%
Pb Ratio-3.604+26%-4.886-2.984-39%3.303-248%8.538-157%25.392-119%
Pe Ratio-287.031+26%-389.129-91.323-77%10.941-3657%-4.057-99%-6.322-98%
Price Per Share7.450-36%10.1009.629+5%11.215-10%10.080+0%11.224-10%
Price To Free Cash Flow Ratio8.758-36%11.87410.058+18%6.926+71%6.990+70%4.821+146%
Price To Total Gains Ratio-60.536+26%-82.0694.391-1969%39.261-309%29.892-375%-24.659-70%
Quick Ratio--0.4681.539-70%3.483-87%2.334-80%2.215-79%
Return On Assets---0.002-0.424+18257%0.042-106%-0.036+1450%-0.053+2178%
Return On Equity---0.016-100%0.076-100%0.409-100%-0.0570%
Total Gains Per Share---0.123-1.490+1111%0.100-223%-0.051-58%-0.071-42%
Usd Book Value---346293226.970-77974350.769-77%573523813.543-160%152364169.891-327%92589939.730-474%
Usd Book Value Change Per Share---0.132-1.595+1111%0.107-223%-0.055-58%-0.076-42%
Usd Book Value Per Share---2.212-0.498-77%3.664-160%0.973-327%0.603-467%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-3.370+48431%0.280-102%-0.415+5874%-0.368+5200%
Usd Free Cash Flow--35622817.61045788265.563-22%68406399.757-48%44270023.336-20%30531050.577+17%
Usd Free Cash Flow Per Share--0.2280.293-22%0.437-48%0.348-35%0.348-35%
Usd Free Cash Flow To Equity Per Share---0.0981.366-107%0.058-269%0.527-119%0.527-119%
Usd Market Cap1248004087.926-36%1691925005.1081612982464.647+5%1878706824.979-10%1737702805.741-3%1984070338.618-15%
Usd Price Per Share7.973-36%10.80910.305+5%12.002-10%10.787+0%12.012-10%
Usd Profit---1086994.435-250558467.134+22951%43766025.917-102%-8552206.212+687%-20132827.954+1752%
Usd Revenue--117552398.129110683183.299+6%102648474.437+15%104250466.235+13%97151019.826+21%
Usd Total Gains Per Share---0.132-1.595+1111%0.107-223%-0.055-58%-0.076-42%
 EOD+3 -5MRQTTM+17 -16YOY+5 -285Y+11 -2210Y+12 -20

3.2. Fundamental Score

Let's check the fundamental score of Ironwood Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-287.031
Price to Book Ratio (EOD)Between0-1-3.604
Net Profit Margin (MRQ)Greater than0-0.009
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.468
Current Ratio (MRQ)Greater than10.845
Debt to Asset Ratio (MRQ)Less than11.735
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.002
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Ironwood Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.500
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets471,073
Total Liabilities817,368
Total Stockholder Equity-346,295
 As reported
Total Liabilities 817,368
Total Stockholder Equity+ -346,295
Total Assets = 471,073

Assets

Total Assets471,073
Total Current Assets233,288
Long-term Assets237,785
Total Current Assets
Cash And Cash Equivalents 92,154
Net Receivables 129,122
Other Current Assets 12,012
Total Current Assets  (as reported)233,288
Total Current Assets  (calculated)233,288
+/-0
Long-term Assets
Property Plant Equipment 18,171
Intangible Assets 3,682
Long-term Assets Other 3,608
Long-term Assets  (as reported)237,785
Long-term Assets  (calculated)25,461
+/- 212,324

Liabilities & Shareholders' Equity

Total Current Liabilities276,101
Long-term Liabilities541,267
Total Stockholder Equity-346,295
Total Current Liabilities
Short Long Term Debt 199,560
Accounts payable 7,830
Other Current Liabilities 8,817
Total Current Liabilities  (as reported)276,101
Total Current Liabilities  (calculated)216,207
+/- 59,894
Long-term Liabilities
Long term Debt 498,309
Capital Lease Obligations Min Short Term Debt17,669
Long-term Liabilities Other 28,415
Long-term Liabilities  (as reported)541,267
Long-term Liabilities  (calculated)544,393
+/- 3,126
Total Stockholder Equity
Total Stockholder Equity (as reported)-346,295
Total Stockholder Equity (calculated)0
+/- 346,295
Other
Capital Stock156
Common Stock Shares Outstanding 156,354
Net Debt 605,715
Net Invested Capital 351,574
Net Working Capital -42,813
Property Plant and Equipment Gross 27,060



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
709,821
701,319
705,079
625,086
605,674
571,095
618,218
416,652
332,050
363,538
315,721
334,343
402,748
404,005
443,538
492,324
559,238
599,344
1,007,218
1,079,371
1,126,927
1,083,381
975,690
1,040,344
1,100,519
1,155,277
603,220
524,063
471,073
471,073524,063603,2201,155,2771,100,5191,040,344975,6901,083,3811,126,9271,079,3711,007,218599,344559,238492,324443,538404,005402,748334,343315,721363,538332,050416,652618,218571,095605,674625,086705,079701,319709,821
   > Total Current Assets 
380,181
357,853
341,487
314,053
311,596
275,727
279,542
248,548
266,435
201,832
220,985
257,638
306,852
333,943
374,275
433,317
495,839
538,246
620,268
695,374
745,225
710,101
617,826
698,994
780,626
866,374
317,599
253,610
233,288
233,288253,610317,599866,374780,626698,994617,826710,101745,225695,374620,268538,246495,839433,317374,275333,943306,852257,638220,985201,832266,435248,548279,542275,727311,596314,053341,487357,853380,181
       Cash And Cash Equivalents 
54,004
134,509
182,132
162,640
125,736
144,788
145,415
141,562
173,172
119,045
98,908
139,231
177,023
231,143
253,252
307,555
362,564
438,469
492,699
574,276
620,129
593,371
504,365
574,188
656,203
740,342
175,321
110,164
92,154
92,154110,164175,321740,342656,203574,188504,365593,371620,129574,276492,699438,469362,564307,555253,252231,143177,023139,23198,908119,045173,172141,562145,415144,788125,736162,640182,132134,50954,004
       Short-term Investments 
251,212
162,020
90,763
62,777
95,680
49,659
35,831
19,836
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000019,83635,83149,65995,68062,77790,763162,020251,212
       Net Receivables 
64,854
51,147
60,357
80,083
82,157
70,651
80,519
65,375
80,950
72,617
103,786
96,570
117,246
91,107
105,379
113,250
122,351
87,152
102,252
101,773
114,042
105,515
102,357
116,545
115,458
115,749
118,990
124,546
129,122
129,122124,546118,990115,749115,458116,545102,357105,515114,042101,773102,25287,152122,351113,250105,37991,107117,24696,570103,78672,61780,95065,37580,51970,65182,15780,08360,35751,14764,854
       Inventory 
1,081
1,513
0
479
735
1,705
1,099
76
0
593
1,735
2,298
648
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006482,2981,7355930761,0991,70573547901,5131,081
       Other Current Assets 
9,030
8,664
8,235
8,074
7,288
8,924
0
0
1,250
1,250
7,676
7,676
1,250
1,250
1,250
1,735
1,735
1,735
12,997
9,104
2,365
2,678
1,250
1,250
1,250
9,033
788
18,112
12,012
12,01218,1127889,0331,2501,2501,2502,6782,3659,10412,9971,7351,7351,7351,2501,2501,2507,6767,6761,2501,250008,9247,2888,0748,2358,6649,030
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
161,706
94,736
76,705
95,896
70,062
69,263
59,007
63,399
61,098
386,950
383,997
381,702
373,280
357,864
341,350
319,893
288,903
285,621
270,453
237,785
237,785270,453285,621288,903319,893341,350357,864373,280381,702383,997386,95061,09863,39959,00769,26370,06295,89676,70594,736161,706000000000
       Property Plant Equipment 
20,512
18,633
17,854
17,175
17,274
16,844
16,335
16,161
17,270
103,850
32,234
31,174
30,172
29,611
28,346
26,192
25,505
24,780
24,080
23,578
22,925
22,257
21,664
21,025
20,311
19,689
19,195
18,586
18,171
18,17118,58619,19519,68920,31121,02521,66422,25722,92523,57824,08024,78025,50526,19228,34629,61130,17231,17432,234103,85017,27016,16116,33516,84417,27417,17517,85418,63320,512
       Goodwill 
785
785
785
785
785
785
785
785
785
785
785
785
785
0
0
0
785
0
0
0
0
0
0
0
0
0
0
0
0
000000000000785000785785785785785785785785785785785785785
       Long Term Investments 
132,521
150,509
171,880
121,836
108,188
113,445
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000113,445108,188121,836171,880150,509132,521
       Intangible Assets 
166,119
165,699
165,278
163,381
159,905
156,429
152,953
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,682
3,682000000000000000000000152,953156,429159,905163,381165,278165,699166,119
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
6,482
997
991
976
1,809
1,791
1,366
643
1,409
1,364
1,340
1,485
1,440
1,357
1,348
1,332
1,305
4,430
4,333
3,608
3,6084,3334,4301,3051,3321,3481,3571,4401,4851,3401,3641,4096431,3661,7911,8099769919976,482000000000
> Total Liabilities 
643,105
671,682
700,209
642,665
595,826
589,147
662,169
613,947
528,421
600,717
535,088
487,390
495,999
475,562
480,390
486,420
496,598
489,152
495,462
499,430
521,016
565,598
442,807
449,281
448,141
448,425
949,997
849,742
817,368
817,368849,742949,997448,425448,141449,281442,807565,598521,016499,430495,462489,152496,598486,420480,390475,562495,999487,390535,088600,717528,421613,947662,169589,147595,826642,665700,209671,682643,105
   > Total Current Liabilities 
91,131
78,893
79,973
64,489
66,027
62,336
94,984
112,582
119,524
118,569
110,861
52,795
40,929
27,595
26,695
32,901
32,173
23,603
134,370
145,694
161,698
147,403
23,298
27,117
25,525
23,843
305,390
280,579
276,101
276,101280,579305,39023,84325,52527,11723,298147,403161,698145,694134,37023,60332,17332,90126,69527,59540,92952,795110,861118,569119,524112,58294,98462,33666,02764,48979,97378,89391,131
       Short-term Debt 
6,227
5,501
392,957
396,340
400,168
11,958
24,861
39,191
47,554
45,961
48,797
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000048,79745,96147,55439,19124,86111,958400,168396,340392,9575,5016,227
       Short Long Term Debt 
6,227
5,501
392,957
396,340
400,168
11,958
24,861
39,191
47,554
45,961
48,797
0
0
0
0
0
0
0
112,852
114,832
116,858
120,581
0
0
0
0
199,083
199,321
199,560
199,560199,321199,0830000120,581116,858114,832112,852000000048,79745,96147,55439,19124,86111,958400,168396,340392,9575,5016,227
       Accounts payable 
62,941
57,502
21,190
17,514
15,958
11,609
23,786
9,332
18,123
11,203
9,908
6,098
3,978
2,781
2,104
1,972
661
842
466
414
935
532
317
795
483
118
3,505
4,698
7,830
7,8304,6983,5051184837953175329354144668426611,9722,1042,7813,9786,0989,90811,20318,1239,33223,78611,60915,95817,51421,19057,50262,941
       Other Current Liabilities 
21,963
15,890
16,715
2,194
442
3,092
8,065
19,842
6,603
15,556
8,433
8,503
8,363
3,133
2,626
4,064
12,110
7,175
3,624
8,737
7,687
5,401
4,552
4,019
3,619
7,061
64,070
14,301
8,817
8,81714,30164,0707,0613,6194,0194,5525,4017,6878,7373,6247,17512,1104,0642,6263,1338,3638,5038,43315,5566,60319,8428,0653,0924422,19416,71515,89021,963
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
482,148
424,227
434,595
455,070
447,967
453,695
453,519
463,885
465,549
361,092
353,736
359,318
418,195
419,509
422,164
422,616
424,582
644,607
569,163
541,267
541,267569,163644,607424,582422,616422,164419,509418,195359,318353,736361,092465,549463,885453,519453,695447,967455,070434,595424,227482,148000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
92,030
30,589
32,594
23,228
23,522
23,821
23,879
23,446
23,006
22,555
22,087
21,611
21,128
20,633
20,137
19,664
19,185
18,693
18,185
17,669
17,66918,18518,69319,18519,66420,13720,63321,12821,61122,08722,55523,00623,44623,87923,82123,52223,22832,59430,58992,030000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
2,723
2,626
492
734
705
602
518
1,223
1,630
1,482
1,594
3,501
5,111
6,491
9,227
9,766
11,824
31,035
30,948
28,415
28,41530,94831,03511,8249,7669,2276,4915,1113,5011,5941,4821,6301,2235186027057344922,6262,723000000000
       Deferred Long Term Liability 
557
2,554
3,515
4,484
5,449
5,860
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,800
0
0
002,800000000000000000000005,8605,4494,4843,5152,554557
> Total Stockholder Equity
66,716
29,637
4,870
-17,579
9,848
-18,052
-43,951
-197,295
-196,371
-237,179
-219,367
-153,047
-93,251
-71,557
-36,852
5,904
62,640
110,192
511,756
579,941
605,911
517,783
532,883
591,063
652,378
706,852
-346,777
-323,216
-346,295
-346,295-323,216-346,777706,852652,378591,063532,883517,783605,911579,941511,756110,19262,6405,904-36,852-71,557-93,251-153,047-219,367-237,179-196,371-197,295-43,951-18,0529,848-17,5794,87029,63766,716
   Common Stock
148
149
150
149
151
152
153
154
154
156
156
157
158
159
160
160
161
162
163
163
162
155
153
153
154
0
156
0
0
001560154153153155162163163162161160160159158157156156154154153152151149150149148
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 000000000000000000000-9-44-91-79-6-24-41-7



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue442,735
Cost of Revenue--
Gross Profit-442,735
 
Operating Income (+$)
Gross Profit-
Operating Expense-274,399
Operating Income168,336-274,399
 
Operating Expense (+$)
Research Development116,085
Selling General Administrative158,314
Selling And Marketing Expenses-
Operating Expense274,399274,399
 
Net Interest Income (+$)
Interest Income18,971
Interest Expense-21,629
Other Finance Cost-0
Net Interest Income-2,658
 
Pretax Income (+$)
Operating Income168,336
Net Interest Income-2,658
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-948,0691,282,083
EBIT - interestExpense = -21,629
-1,002,239
-980,610
Interest Expense21,629
Earnings Before Interest and Taxes (EBIT)--926,440
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-948,069
Tax Provision-83,490
Net Income From Continuing Ops-1,031,559-1,031,559
Net Income-1,002,239
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,113,7472,658
 

Technical Analysis of Ironwood Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ironwood Pharmaceuticals Inc. The general trend of Ironwood Pharmaceuticals Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ironwood Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ironwood Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10 < 10.60 < 13.40.

The bearish price targets are: .

Tweet this
Ironwood Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ironwood Pharmaceuticals Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ironwood Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartIronwood Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ironwood Pharmaceuticals Inc. The current adx is .

Ironwood Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartIronwood Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Stochastic Oscillator ChartIronwood Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartIronwood Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartIronwood Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Williams %R ChartIronwood Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Average True Range (ATR) ChartIronwood Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartIronwood Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartIronwood Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ironwood Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Ironwood Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ironwood Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose7.500
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ironwood Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Ironwood Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ironwood Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ironwood Pharmaceuticals Inc

I send you an email if I find something interesting about Ironwood Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ironwood Pharmaceuticals Inc.

Receive notifications about Ironwood Pharmaceuticals Inc in your mailbox!